Latest Trials
| EudraCT Number: 2009-017267-41 | Sponsor Protocol Number: CQAV680A2201E1 | Start Date: | |||||||||||
| Sponsor Name: Novartis Pharma Services AG | |||||||||||||
| Full Title: A randomized, double-blind, parallel group study to compare the pharmacodynamics/efficacy, safety and pharmacokinetics of QAV680 versus placebo in patients with moderate persistent asthma | |||||||||||||
| Medical condition: Moderate persistent asthma | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||